The agreement is part of Global Fund’s COVID-19 Response Mechanism (C19RM), the organisation’s primary channel for providing grant support to low- and middle-income countries to purchase COVID-19 tests, treatments, personal protective equipment and critical elements of ‘health systems strengthening’.
Albert Bourla, chairman and chief executive officer, Pfizer, said: “After so much disruption and loss due to COVID-19, we must continue to accelerate access to Paxlovid as a treatment option for high-risk patients in all regions of the world along with test and treat programmes that help get treatment quickly to those in need…
